|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
Vaginosis, bacterial |
|
Infection, vaginal cuff |
| |
|
|
SIDE EFFECTS:
|
|
Cervicitis, vaginitis, or vulvovaginal pruritus, primarily due to Candida albicans |
|
CNS effects |
|
gastrointestinal disturbances |
|
Hypersensitivity |
|
Cervicitis, vaginitis, or vulvovaginal pruritus, primarily due to Candida albicans |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
>> Gastrointestinal disease, history of, especially ulcerative colitis, regional enteritis, or antibiotic-associated colitis |
|
|
ADULT DOSE:
|
|
Anti-infective (vaginal)-
For nonpregnant females: Intravaginal, 100 mg (one applicatorful) into vagina once a day, preferably at bedtime, for three or seven consecutive days.
For pregnant females (second or third trimesters): Intravaginal, 100 mg (one applicatorful) into vagina once a day, preferably at bedtime, for seven consecutive days. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Safety and efficacy have not been established.
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|